Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.

Brain and behavior - 1 Jan 2018

Warø Bjørg Johanne, Aasly Jan O

Abstract excerpt

Objectives: To compare the risk of non-skin cancer in LRRK2 mutation carriers and individuals with idiopathic Parkinson's disease (iPD), explore the age at which LRRK2 mutation carriers have cancer compared to iPD subjects, and clarify whether certain cancers are more closely associated with the LRRK2 mutation than iPD. Materials and Methods: Demographic data and cancer outcomes from 830 iPD patients and 103...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Neoplasms

Share to Norway

Share to Parkinson Disease

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 29568677
DOI: 10.1002/brb3.858
PMCID: PMC5853627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.PMID 29568677Read ↗

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.Semantic proximity Read ↗

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.Semantic proximity Read ↗

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.Semantic proximity Read ↗

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.Semantic proximity Read ↗

A Review of the Association Between Parkinson Disease and Malignant Melanoma.Semantic proximity Read ↗

Cancer in Parkinson's Disease: An Approximation to the Main Risk Factors.Semantic proximity Read ↗

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.Semantic proximity Read ↗

The association between Parkinson's disease and melanomaSemantic proximity Read ↗

Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.Semantic proximity Read ↗

No association between Parkinson disease alleles and the risk of melanoma.Semantic proximity Read ↗

Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.Semantic proximity Read ↗

Family history of melanoma and Parkinson disease risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.